title: Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge.
abstract: cDNA clones of the genes encoding either the hemagglutinin (HA) or fusion (F) proteins of the Edmonston strain of measles virus (MV) were expressed in vaccinia virus recombinants. Immunofluorescence analysis detected both proteins on the plasma membranes of unfixed cells as well as internally in fixed cells. Immunoprecipitation of metabolically radiolabeled infected-cell extracts by using specific sera demonstrated a 76-kDa HA polypeptide and gene products of 60, 44, and 23 kDa which correspond to a MV F precursor and cleavage products F0, F1, and F2, respectively. Neither recombinant induced cell fusion of Vero cells when inoculated individually, but efficient cell fusion was readily observed upon coinfection of cells with both recombinants. Inoculation of dogs with the vaccinia virus-MV F recombinant (VV-MVF) did not give rise to detectable MV-neutralizing antibody. Inoculation of dogs with the vaccinia virus-MV HA recombinant (VV-MVHA) or coinoculation with both recombinants (VV-MVF and VV-MVHA) induced significant MV-neutralizing titers that were increased following a booster inoculation. Inoculation of dogs with the vaccinia virus recombinants or with MV failed to induce canine distemper virus (CDV)-neutralizing antibodies. Upon challenge with a lethal dose of virulent CDV, signs of infection were observed in dogs inoculated with (VV-MVF). No symptoms of disease were observed in dogs that had been vaccinated with VV-MVHA or with VV-MVHA and VV-MVF and then challenged with CDV. All dogs vaccinated with the recombinant viruses as well as those inoculated with MV or a vaccine strain of CDV survived CDV challenge.
authors.affiliation: Virogenetics Corporation, Troy, New York 12180.
authors.forename: J
authors.initials: J
authors.lastname: Taylor
authors.forename: S
authors.initials: S
authors.lastname: Pincus
authors.forename: J
authors.initials: J
authors.lastname: Tartaglia
authors.forename: C
authors.initials: C
authors.lastname: Richardson
authors.forename: G
authors.initials: G
authors.lastname: Alkhatib
authors.forename: D
authors.initials: D
authors.lastname: Briedis
authors.forename: M
authors.initials: M
authors.lastname: Appel
authors.forename: E
authors.initials: E
authors.lastname: Norton
authors.forename: E
authors.initials: E
authors.lastname: Paoletti
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D001483:Base Sequence; D002459:Cell Fusion; D003429:Cross Reactions; D004216:Distemper / Q000517:prevention & control*; D004217:Distemper Virus, Canine / Q000276:immunology; D004285:Dogs; D005455:Fluorescent Antibody Technique; D015967:Gene Expression Regulation, Viral; D015726:Giant Cells; D006389:Hemagglutinins, Viral / Q000235:genetics* / Q000276:immunology; D007117:Immunization, Secondary / Q000662:veterinary; D008459:Measles virus / Q000235:genetics* / Q000276:immunology; D008969:Molecular Sequence Data; D011233:Precipitin Tests; D013047:Specific Pathogen-Free Organisms; D014611:Vaccination / Q000662:veterinary; D014614:Vaccines, Synthetic / Q000276:immunology; D014616:Vaccinia virus / Q000235:genetics; D014709:Vero Cells; D014760:Viral Fusion Proteins / Q000235:genetics* / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology
chemical_list: D000914:Antibodies, Viral; D006389:Hemagglutinins, Viral; D014614:Vaccines, Synthetic; D014760:Viral Fusion Proteins; D014765:Viral Vaccines